{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T23:10:10Z","timestamp":1744153810057},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T00:00:00Z","timestamp":1577923200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T00:00:00Z","timestamp":1577923200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s12185-019-02808-6","type":"journal-article","created":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T18:08:30Z","timestamp":1577988510000},"page":"388-395","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["High-dose dexamethasone therapy as the initial treatment for idiopathic thrombocytopenic purpura"],"prefix":"10.1007","volume":"111","author":[{"given":"Ken","family":"Takase","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moe","family":"Kadono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Yoshio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Hirabayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuo","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morio","family":"Sawamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichiro","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikuyo","family":"Tsutsumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maki","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youko","family":"Suehiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michihiro","family":"Hidaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisayuki","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroatsu","family":"Iida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maki","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terutoshi","family":"Hishita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Kada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko M.","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,2]]},"reference":[{"key":"2808_CR1","first-page":"433","volume":"53","author":"K Fujimura","year":"2012","unstructured":"Fujimura K, Miyakawa Y, Kurata Y, Kuwana M, Tomiyama Y. Murata M (2012) Reference guide for management of adult idiopathic thrombocytopenic purpura (ITP) 2012 version. Rinsho Ketsueki Nihon Rinsho Ketsueki Gakkai\/Japan Society of Clinical Hematology. 2012;53:433\u201342.","journal-title":"Rinsho Ketsueki Nihon Rinsho Ketsueki Gakkai\/Japan Society of Clinical Hematology."},{"key":"2808_CR2","doi-asserted-by":"publisher","first-page":"4190","DOI":"10.1182\/blood-2010-08-302984","volume":"117","author":"C Neunert","year":"2011","unstructured":"Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther MA, et al. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011;117:4190\u2013207.","journal-title":"Blood"},{"key":"2808_CR3","first-page":"433","volume":"53","author":"K Fujimura","year":"2012","unstructured":"Fujimura K, Miyakawa Y, Kurata Y, Kuwana M, Tomiyama Y, Murata M. Reference guide for management of adult idiopathic thrombocytopenic purpura (ITP) 2012 version. Rinsho Ketsueki. 2012;53:433\u201342.","journal-title":"Rinsho Ketsueki"},{"key":"2808_CR4","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1182\/blood-2005-12-015222","volume":"109","author":"MG Mazzucconi","year":"2007","unstructured":"Mazzucconi MG, Fazi P, Bernasconi S, De Rossi G, Leone G, Gugliotta L, et al. Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience. Blood. 2007;109:1401\u20137.","journal-title":"Blood"},{"key":"2808_CR5","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/S0002-9343(99)80342-8","volume":"98","author":"R Stasi","year":"1995","unstructured":"Stasi R, Stipa E, Masi M, Cecconi M, Scim\u00f2 MT, Oliva F, et al. Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura. Am J Med. 1995;98:436\u201342.","journal-title":"Am J Med"},{"key":"2808_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1365-2257.2004.00591.x","volume":"26","author":"J Zimmer","year":"2004","unstructured":"Zimmer J, Andres E, Noel E, Koumarianou A, Blickle J-F, Maloisel F. Current management of adult idiopathic thrombocytopenic purpura in practice: a cohort study of 201 patients from a single center. Clin Lab Haematol. 2004;26:137\u201342.","journal-title":"Clin Lab Haematol"},{"key":"2808_CR7","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1056\/NEJMoa030254","volume":"349","author":"Y Cheng","year":"2003","unstructured":"Cheng Y, Wong RSM, Soo YOY, Chui CH, Lau FY, Chan NPH, et al. Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone. N Engl J Med. 2003;349:831\u20136.","journal-title":"N Engl J Med"},{"key":"2808_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/2008-2231-20-7","volume":"20","author":"MA Mashhadi","year":"2012","unstructured":"Mashhadi MA, Kaykhaei MA, Sepehri Z, Miri-Moghaddam E. Single course of high dose dexamethasone is more effective than conventional prednisolone therapy in the treatment of primary newly diagnosed immune thrombocytopenia. DARU J Pharm Sci. 2012;20:7.","journal-title":"DARU J Pharm Sci"},{"key":"2808_CR9","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s11239-013-0939-3","volume":"37","author":"K Sakamoto","year":"2014","unstructured":"Sakamoto K, Nakasone H, Tsurumi S, Sasaki K, Mitani K, Kida M, et al. Prednisone versus high-dose dexamethasone for untreated primary immune thrombocytopenia. A retrospective study of the Japan Hematology and Oncology Clinical Study Group. J Thromb Thrombolysis. 2014;37:279\u201386.","journal-title":"J Thromb Thrombolysis"},{"key":"2808_CR10","doi-asserted-by":"publisher","first-page":"859","DOI":"10.2169\/internalmedicine.51.7005","volume":"51","author":"K Nakazaki","year":"2012","unstructured":"Nakazaki K, Hosoi M, Hangaishi A, Ichikawa M, Nannya Y, Kurokawa M. Comparison between pulsed high-dose dexamethasone and daily corticosteroid therapy for adult primary immune thrombocytopenia: a retrospective study. Intern Med. 2012;51:859\u201363.","journal-title":"Intern Med"},{"key":"2808_CR11","first-page":"197","volume":"72","author":"K Takase","year":"2018","unstructured":"Takase K, Kada A, Iwasaki H, Yoshida I, Sawamura M, Yoshio N, et al. High-dose dexamethasone therapy as the initial treatment for idiopathic thrombocytopenic purpura: protocol for a multicenter, open-label single arm trial. Acta Med Okayama. 2018;72:197\u2013201.","journal-title":"Acta Med Okayama"},{"key":"2808_CR12","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","volume":"113","author":"F Rodeghiero","year":"2009","unstructured":"Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113:2386\u201393.","journal-title":"Blood"},{"key":"2808_CR13","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1182\/blood.V97.9.2549","volume":"97","author":"JEA Portielje","year":"2001","unstructured":"Portielje JEA. Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood. 2001;97:2549\u201354.","journal-title":"Blood"},{"key":"2808_CR14","unstructured":"Japan Intractable Diseases Information Center.Survey on blood coagulation disorders; 2019. https:\/\/www.nanbyou.or.jp\/entry\/303. Accessed 24 July 2019 (in Japanese)."},{"key":"2808_CR15","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1002\/ajh.25275","volume":"93","author":"H Al-Samkari","year":"2018","unstructured":"Al-Samkari H, Kuter DJ. Thrombopoietin level predicts response to treatment with eltrombopag and romiplostim in immune thrombocytopenia. Am J Hematol. 2018;93:1501\u20138.","journal-title":"Am J Hematol"},{"issue":"3","key":"2808_CR16","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1182\/blood-2015-07-659656","volume":"127","author":"Yu Wei","year":"2016","unstructured":"Wei Y, Ji X-B, Wang Y-W, Wang J-X, Yang E-Q, Wang Z-C, et al. High-dose dexamethasone vs prednisone for treatment of adult immune thrombocytopenia: a prospective multicenter randomized trial. Blood. 2016;127:296\u2013302 (quiz 370).","journal-title":"Blood"},{"key":"2808_CR17","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1111\/j.1572-0241.2005.41641.x","volume":"100","author":"T Suzuki","year":"2005","unstructured":"Suzuki T, Matsushima M, Masui A, Watanabe K-I, Takagi A, Ogawa Y, et al. Effect of Helicobacter pylori eradication in patients with chronic idiopathic thrombocytopenic purpura\u2014a randomized controlled trial. Am J Gastroenterol. 2005;100:1265\u201370.","journal-title":"Am J Gastroenterol"},{"key":"2808_CR18","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s00277-005-1071-z","volume":"84","author":"Y Tsutsumi","year":"2005","unstructured":"Tsutsumi Y, Kanamori H, Yamato H, Ehira N, Kawamura T, Umehara S, et al. Randomized study of Helicobacter pylori eradication therapy and proton pump inhibitor monotherapy for idiopathic thrombocytopenic purpura. Ann Hematol. 2005;84:807\u201311.","journal-title":"Ann Hematol"},{"key":"2808_CR19","first-page":"1243","volume":"29","author":"C-X Li","year":"2009","unstructured":"Li C-X, Liu D-J, Pan C-Q, Sang X-F, Li X. Effect of Helicobacter pylori eradication on childhood acute idiopathic thrombocytopenic purpura. Nan Fang Yi Ke Da Xue Xue Bao. 2009;29:1243\u20134.","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"2808_CR20","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/pbc.21991","volume":"53","author":"S Treepongkaruna","year":"2009","unstructured":"Treepongkaruna S, Sirachainan N, Kanjanapongkul S, Winaichatsak A, Sirithorn S, Sumritsopak R, et al. Absence of platelet recovery following Helicobacter pylori eradication in childhood chronic idiopathic thrombocytopenic purpura: a multi-center randomized controlled trial. Pediatr Blood Cancer. 2009;53:72\u20137.","journal-title":"Pediatr Blood Cancer"},{"key":"2808_CR21","first-page":"419","volume":"21","author":"Y Tang","year":"2013","unstructured":"Tang Y, Wang S-C, Wang L-J, Liu Y, Wang H-Y, Wang Z-J. Clinical significance of Helicobacter pylori in children with idiopathic thrombocytopenic purpura. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013;21:419\u201321.","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"2808_CR22","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3109\/09537104.2014.911836","volume":"26","author":"HSH Brito","year":"2015","unstructured":"Brito HSH, Braga JAP, Loggetto SR, Machado RS, Granato CFH, Kawakami E. Helicobacter pylori infection and immune thrombocytopenic purpura in children and adolescents: a randomized controlled trial. Platelets. 2015;26:336\u201341.","journal-title":"Platelets"},{"key":"2808_CR23","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1111\/j.1538-7836.2006.02091.x","volume":"4","author":"M Kuwana","year":"2006","unstructured":"Kuwana M, Kurata Y, Fujimura K, Fujisawa K, Wada H, Nagasawa T, et al. Preliminary laboratory based diagnostic criteria for immune thrombocytopenic purpura: evaluation by multi-center prospective study. J Thromb Haemost. 2006;4:1936\u201343.","journal-title":"J Thromb Haemost"},{"key":"2808_CR24","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1182\/blood-2015-03-631937","volume":"126","author":"PY-I Choi","year":"2015","unstructured":"Choi PY-I, Roncolato F, Badoux X, Ramanathan S, Ho S-J, Chong BH. A novel triple therapy for ITP using high-dose dexamethasone, low-dose rituximab, and cyclosporine (TT4). Blood. 2015;126:500\u20133.","journal-title":"Blood"},{"key":"2808_CR25","doi-asserted-by":"publisher","first-page":"3906","DOI":"10.1182\/blood-2014-01-549360","volume":"123","author":"D Gomez-Almaguer","year":"2014","unstructured":"Gomez-Almaguer D, Herrera-Rojas MA, Jaime-Perez JC, Gomez-De Leon A, Cantu-Rodriguez OG, Gutierrez-Aguirre CH, et al. Eltrombopag and high-dose dexamethasone as frontline treatment of newly diagnosed immune thrombocytopenia in adults. Blood. 2014;123:3906\u20138.","journal-title":"Blood"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-019-02808-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-019-02808-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-019-02808-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:58:55Z","timestamp":1609462735000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-019-02808-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,2]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["2808"],"URL":"https:\/\/doi.org\/10.1007\/s12185-019-02808-6","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,2]]},"assertion":[{"value":"18 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"HN reports grants and personal fees from Janssen Pharmaceutical K.K., Mundipharma K.K., Celgene Corporation, Bayer Yakuhin Ltd., Takeda Pharmaceutical Co., Ltd., Kyowa Hakko Kirin Co., Ltd., Esai Co., Ltd., Bristol-Myers Squibb, Ono Pharmaceutical Co., Ltd., Gilead Sciences Inc., Zenyaku Kogyo Co., Ltd., AstraZeneca plc., and SymBio Pharmaceuticals Limited, outside the submitted work; grants from Abbvie G.K., Solasia Pharma K.K., HUYA Bioscience International, Otsuka Pharmaceutical Co., Ltd., and IQVIA service Japan K.K., outside the submitted work; personal fees from Roche Ltd., Sanofi K.K., outside the submitted work. HY reports grants from Astellas, outside the submitted work. AK reports personal fees from Bayer Yakuhin, Ltd. for a member of independent data monitoring committee of clinical trials, outside the submitted work. All other authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}